Tag: pediatric psychiatry
-
Why Prozac Falls Short for Childhood Depression: Experts Urge Guideline Change
New Findings Question Prozac’s Effectiveness in Young Patients In a development that could reshape how doctors treat depression in children and adolescents, recent analyses indicate that fluoxetine (Prozac) provides no clear clinical advantage over placebo for young patients. Across multiple studies, the medication did not demonstrate consistent improvements in mood, functioning, or long-term outcomes when…
-
Experts Say Prozac Fails to Beat Placebo for Child Depression: A Wake-Up Call for Guidelines
Prozac and the debate over pediatric depression treatment New analyses have intensified the debate over using Prozac (fluoxetine) to treat depression in children and adolescents. Leading experts say current clinical guidelines should be revised because robust evidence shows the medication offers no meaningful advantage over placebo for younger patients. The discussion comes as mental health…